The filing ratchets up a confrontation between the pharmaceutical industry and the Liberal government of Prime Minister Justin Trudeau, which has vowed to make affordability a key plank of its election campaign. Continue reading →

There are a number of ways drug companies can pay doctors for work, including delivering speeches and participating in clinical trials. Continue reading →

Medical schools across Canada have their own policies on pharma donations and industry interaction. Here’s what they are. Continue reading →

The opioid crisis has highlighted the power of drug manufacturers when it comes to swaying physicians’ prescribing habits, but exposure to industry starts much earlier on. Continue reading →

Typically, a vial of insulin Type 1 diabetics need to regulate their blood sugar costs about US$340 in the United States, roughly 10 times the price in Canada. Continue reading →

Artist Domenic Esposito is protesting the opioid crisis by placing a giant sculpture of a burnt spoon in front of the offices of a Rhode Island pharmaceutical company. Continue reading →

U.S. prosecutors say Canada Drugs’ business model is based entirely on illegally importing unapproved and misbranded drugs not just from Canada, but from all over the world. Continue reading →

What no one is asking is, how did we get here and who is responsible? That is where the solution lies. Continue reading →

The average wholesale price of a 60 ml bottle of Lomotil went from about $16 a bottle to $84. Continue reading →